DocuSign Ventures will invest in technologies such as process automation, smart contracts, digital payments and identity verification.

Fubon Financial Holdings' Fubon Life subsidiary and CTBC Financial Holdings' Taiwan Life are both backing Dragoneer Opportunities Fund VI.

Neurological disease drug developer Axial raised $37.3m from investors including Taiho Ventures while Best Buy is purchasing OSF and Legal & General-backed remote healthcare technology provider Current Health.

Q&A with Tarik Galijasevic, managing director, Allstate Strategic Ventures

The SoftBank vehicle provided the cash at a $4bn valuation and it will support the outdoor apparel brand's domestic and international growth.

Singapore Exchange reinvested in the bond trading platform developer at a $2.4bn valuation, in a round led by Point Break Capital Management.

Eli Lilly participated in a series B round for the cardiorenal treatment specialist that will support clinical drug trials, boosting its overall funding to $193m.

Allianz Life Ventures contributed to a round that boosted the investment tools provider's overall funding to $120m.

The CRM Platform Fund, formed three years after the unit's inaugural fund, will invest in enterprise software producers from seed to late stage.

Orbia, Koura, Hitachi, JLR, TDK, Doral and Trumpf took part in a second $70m round to be announced by the battery recycling service provider in under a month.